CVS subsidiary Oak Street Health fined $60M for kickback scheme

CVS-owned primary care chain Oak Street Health has agreed to a $60 million settlement to resolve allegations it participated in an illegal kickback scheme, the U.S. Department of Justice (DOJ)  announced.

The DOJ said from September 2020 to December 2022, the physician group allegedly paid insurance agents $200 per-patient kickbacks to entice their plan members, specifically seniors, to sign up for services at Oak Street. 

Patients were connected to a three-way call with a provider and the insurance agent to seal th deal through a “warm transfer,” the DOJ said. 

The scheme specifically targeted patients enrolled in Medicare Advantage plans, and reimbursement funds from those patients were allegedly used to pay the kickbacks—meaning, government funds were illegally allocated. 

Oak City called the initiative the “Client Awareness Program” and apparently were not shy about offering the kickbacks to insurance agents. The program shut down in 2022. CVS Health acquired Oak Street in May 2023, after the kickbacks for referrals stopped. 

“Kickbacks impose hidden costs on the federal health care system and compromise medical choice and decision-making,” Special Agent in Charge, Mario Pinto of the Department of Health and Human Services Office of the Inspector General, said in a statement. “Working determinedly with our law enforcement partners, HHS-OIG will continue to protect the integrity of federal health care programs, and we encourage the public to come forward with information about violative conduct.”

As part of the settlement, Oak Street admits it “knowingly submitted, and caused the submission of, false claims to Medicare arising from kickbacks to agents” in violation of federal law, the DOJ said. 

A whistleblower tipped the DOJ off about the scheme under provisions of the False Claim Act. That individual, Joseph Stinson, is set to receive a $9.9 million reward from the settlement fund. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”